| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Neurophysiology Vol. 78 No. 6 December 1997,
pp. 3008-3018
Copyright ©1997 The American Physiological Society
Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California 92037
Tallent, Melanie K. and George R. Siggins. Somatostatin depresses excitatory but not inhibitory neurotransmission in rat CA1 hippocampus. J. Neurophysiol. 78: 3008-3018, 1997. In rat CA1 hippocampal pyramidal neurons (HPNs), somatostatin (SST) has inhibitory postsynaptic actions, including hyperpolarization of the membrane at rest and augmentation of the K+ M-current. However, the effects of SST on synaptic transmission in this brain region have not been well-characterized. Therefore we used intracellular voltage-clamp recordings in rat hippocampal slices to assess the effects of SST on pharmacologically isolated synaptic currents in HPNs. SST depressed both (R,S)-
-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate and N-methyl-D-aspartate (NMDA) receptor-mediated excitatory postsynaptic currents (EPSCs) in a reversible manner, with an apparent IC50 of 22 nM and a maximal effect at 100 nM. In contrast, SST at concentrations up to 5 µM had no direct effects on either 
-aminobutyric acid-A (GABAA) or GABAB receptor-mediated inhibitory postsynaptic currents (IPSCs). The depression of EPSCs by SST was especially robust during hyperexcited states when polysynaptic EPSCs were present, suggesting that this peptide could play a compensatory role during seizurelike activity. SST effects were greatly attenuated by the alkylating agent N-ethylmaleimide, thus implicating a transduction mechanism involving the Gi/Go family of G-proteins. Use of 2 M Cs+ in the recording electrode blocked the postsynaptic modulation of K+ currents by SST, but did not alter the effects of SST on EPSCs, indicating that postsynaptic K+ currents are not involved in this action of SST. However, 2 mM external Ba2+ blocked the effect of SST on EPSCs, suggesting that presynaptic K+ channels or other presynaptic mechanisms may be involved. These findings and previous results from our laboratory show that SST has multiple inhibitory effects in hippocampus.
This article has been cited by other articles:
|
|
 |
|
  C. Qiu, T. Zeyda, B. Johnson, U. Hochgeschwender, L. de Lecea, and M. K. Tallent Somatostatin Receptor Subtype 4 Couples to the M-Current to Regulate Seizures J. Neurosci., April 2, 2008; 28(14): 3567 - 3576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Vervaeke, N. Gu, C. Agdestein, H. Hu, and J. F. Storm Kv7/KCNQ/M-channels in rat glutamatergic hippocampal axons and their role in regulation of excitability and transmitter release J. Physiol., October 1, 2006; 576(1): 235 - 256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Momiyama and L. Zaborszky Somatostatin Presynaptically Inhibits Both GABA and Glutamate Release Onto Rat Basal Forebrain Cholinergic Neurons J Neurophysiol, August 1, 2006; 96(2): 686 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, M. Toledo-Rodriguez, A. Gupta, C. Wu, G. Silberberg, J. Luo, and H. Markram Anatomical, physiological and molecular properties of Martinotti cells in the somatosensory cortex of the juvenile rat J. Physiol., November 15, 2004; 561(1): 65 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Z. Strowski, M. Kohler, H. Y. Chen, M. E. Trumbauer, Z. Li, D. Szalkowski, S. Gopal-Truter, J. K. Fisher, J. M. Schaeffer, A. D. Blake, et al. Somatostatin Receptor Subtype 5 Regulates Insulin Secretion and Glucose Homeostasis Mol. Endocrinol., January 1, 2003; 17(1): 93 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Baratta, T. Lamp, and M. K. Tallent Somatostatin Depresses Long-Term Potentiation and Ca2+ Signaling in Mouse Dentate Gyrus J Neurophysiol, December 1, 2002; 88(6): 3078 - 3086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Straiker, C. R. Borden, and J. M. Sullivan G-Protein alpha Subunit Isoforms Couple Differentially to Receptors that Mediate Presynaptic Inhibition at Rat Hippocampal Synapses J. Neurosci., April 1, 2002; 22(7): 2460 - 2468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Tallent, S. G. Madamba, and G. R. Siggins Nociceptin Reduces Epileptiform Events in CA3 Hippocampus via Presynaptic and Postsynaptic Mechanisms J. Neurosci., September 1, 2001; 21(17): 6940 - 6948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schreff, S. Schulz, M. Handel, G. Keilhoff, H. Braun, G. Pereira, M. Klutzny, H. Schmidt, G. Wolf, and V. Hollt Distribution, Targeting, and Internalization of the sst4 Somatostatin Receptor in Rat Brain J. Neurosci., May 15, 2000; 20(10): 3785 - 3797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Madamba, P. Schweitzer, and G. R. Siggins Nociceptin Augments K+ Currents in Hippocampal CA1 Neurons by Both ORL-1 and Opiate Receptor Mechanisms J Neurophysiol, October 1, 1999; 82(4): 1776 - 1785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Tallent and G. R. Siggins Somatostatin Acts in CA1 and CA3 to Reduce Hippocampal Epileptiform Activity J Neurophysiol, April 1, 1999; 81(4): 1626 - 1635. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
